PuraPharm (HKG:1498) revised the timetable for its proposed capital reduction and subdivision of unissued shares to Feb. 24, according to a Monday filing with the Hong Kong bourse.
The court hearing for confirmation is scheduled for Jan. 27, in the Cayman Islands. Subject to approval, the changes will take effect on Feb. 24, with trading in the new ordinary shares commencing the same day.
Shareholders can exchange old certificates for new ones from Feb. 24 to March 24.